NewAge (NewAge) COGS-to-Revenue : 0.34 (As of Sep. 2021)

View and export this data going back to 2014. Start your Free Trial

What is NewAge COGS-to-Revenue?

NewAge's Cost of Goods Sold for the three months ended in Sep. 2021 was $33.6 Mil. Its Revenue for the three months ended in Sep. 2021 was $99.6 Mil.

NewAge's COGS to Revenue for the three months ended in Sep. 2021 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. NewAge's Gross Margin % for the three months ended in Sep. 2021 was 66.28%.

NewAge COGS-to-Revenue Historical Data

The historical data trend for NewAge's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAge COGS-to-Revenue Chart

NewAge Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

COGS-to-Revenue

Get a 7-Day Free Trial

0.77

0.76

0.82

0.40

0.36

NewAge Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
COGS-to-Revenue	Get a 7-Day Free Trial															0.40	0.33	0.30	0.32	0.34

NewAge COGS-to-Revenue Calculation

NewAge's COGS to Revenue for the fiscal year that ended in Dec. 2020 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	101.982	/	279.471
	=	0.36

NewAge's COGS to Revenue for the quarter that ended in Sep. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	33.567	/	99.553
	=	0.34

NewAge (OTCPK:NBEVQ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

NewAge's Gross Margin % for the three months ended in Sep. 2021 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	33.567 / 99.553
	=	66.28 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

NewAge COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of NewAge's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAge (NewAge) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Beverages - Non-Alcoholic » NewAge Inc (OTCPK:NBEVQ) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2420 17th Street, Suite 220, Denver, CO, USA, 80202

Website

http://www.newage.com

NewAge Inc is engaged in the business of developing, marketing, selling, and distributing a portfolio of healthy products sold primarily through a direct to customer business model using a team of brand partners and distributors to help market and sell the portfolio of brands. Its Direct/Social Selling segment is engaged in the development, manufacturing, and marketing of a portfolio of healthy products in three core category platforms including health and wellness, healthy appearance, and nutritional performance all sold primarily via e-commerce and through a direct route to market. It has a business presence in the US, Japan, China and other countries.

Executives

Michele Crocker	director	7158 FLSMIDTH DRIVE, SUITE 250 MIDVALE UT 84047
Judith Lynne Hammerschmidt	director	3511 CAMBRIDGE ROAD, DURHAM 1W 27707-4509
Ed Brennan	director	3018 WEST LAKE ROAD SKANEATELES NY 13152
Kevin Manion	officer: Chief Financial Officer	1141 CUMMINGS ROAD, SANTA PAULA CA 93060
Fred W Cooper	director	3838 W PARKWAY BLVD, C/O USANA HEALTH SCIENCES INC, SALT LAKE CITY UT 84120
Reginald Kapteyn	director	16325 WEST WILLOW DRIVE SPRING LAKE MI 49456
Amy L. Kuzdowicz	director	2376 TALL OAKS DRIVE TROY MI 48098
Gregory Fea	director	1700 EAST 68TH AVENUE DENVER CO 80229
David Vanderveen	officer: Chief Operating Officer	2420 17TH STREET, SUITE 220 DENVER CO 80202
Alicia Syrett	director	2420 17TH STREET, SUITE 220, DENVER CO 80202
Timothy J Haas	director	ONE COCA COLA PLAZA ATLANTA GA 30313
Julie Garlikov	officer: Chief Marketing Officer	2420 17TH STREET, SUITE 220, DENVER CO 80202
Brent D Willis	director, officer: CEO	4211 W BOY SCOUT BLVD, SUITE 290, TAMPA FL 33607
Gregory A Gould	officer: CFO	1111 MAIN STREET, SUITE 660, VANCOUVER WA 98660
Richard C Rife	officer: See Remarks	1903 N HEATHER DRIVE OREM UT 84097